BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1356 related articles for article (PubMed ID: 26447875)

  • 1. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
    Esposito A; Criscitiello C; Curigliano G
    Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of radiotherapy and immune checkpoint inhibitors.
    Pilones KA; Vanpouille-Box C; Demaria S
    Semin Radiat Oncol; 2015 Jan; 25(1):28-33. PubMed ID: 25481263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unlocking the combination: potentiation of radiation-induced antitumor responses with immunotherapy.
    Wattenberg MM; Fahim A; Ahmed MM; Hodge JW
    Radiat Res; 2014 Aug; 182(2):126-38. PubMed ID: 24960415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors.
    Derer A; Frey B; Fietkau R; Gaipl US
    Cancer Immunol Immunother; 2016 Jul; 65(7):779-86. PubMed ID: 26590829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment.
    Vanpouille-Box C; Pilones KA; Wennerberg E; Formenti SC; Demaria S
    Vaccine; 2015 Dec; 33(51):7415-7422. PubMed ID: 26148880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic immunotherapy strategies for cancer: mechanisms and clinical development.
    Aguilar LK; Guzik BW; Aguilar-Cordova E
    J Cell Biochem; 2011 Aug; 112(8):1969-77. PubMed ID: 21465529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining radiotherapy and immunotherapy: a revived partnership.
    Demaria S; Bhardwaj N; McBride WH; Formenti SC
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):655-66. PubMed ID: 16199306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining antibody-drug conjugates and immune-mediated cancer therapy: What to expect?
    Gerber HP; Sapra P; Loganzo F; May C
    Biochem Pharmacol; 2016 Feb; 102():1-6. PubMed ID: 26686577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy and immunotherapy: a beneficial liaison?
    Weichselbaum RR; Liang H; Deng L; Fu YX
    Nat Rev Clin Oncol; 2017 Jun; 14(6):365-379. PubMed ID: 28094262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Local Radiation Therapy in Cancer Immunotherapy.
    Demaria S; Golden EB; Formenti SC
    JAMA Oncol; 2015 Dec; 1(9):1325-32. PubMed ID: 26270858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy.
    van Gulijk M; Dammeijer F; Aerts JGJV; Vroman H
    Front Immunol; 2018; 9():2759. PubMed ID: 30568653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenic anti-cancer chemotherapy as an emerging concept.
    Haynes NM; van der Most RG; Lake RA; Smyth MJ
    Curr Opin Immunol; 2008 Oct; 20(5):545-57. PubMed ID: 18573339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune checkpoint inhibitor combinations in solid tumors: opportunities and challenges.
    Kyi C; Postow MA
    Immunotherapy; 2016 Jun; 8(7):821-37. PubMed ID: 27349981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune checkpoint modulation: rational design of combination strategies.
    Zamarin D; Postow MA
    Pharmacol Ther; 2015 Jun; 150():23-32. PubMed ID: 25583297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation therapy to enhance tumor immunotherapy: a novel application for an established modality.
    Ko EC; Formenti SC
    Int J Radiat Biol; 2019 Jul; 95(7):936-939. PubMed ID: 31120369
    [No Abstract]   [Full Text] [Related]  

  • 16. Antitumor immune responses induced by ionizing irradiation and further immune stimulation.
    Frey B; Rubner Y; Kulzer L; Werthmöller N; Weiss EM; Fietkau R; Gaipl US
    Cancer Immunol Immunother; 2014 Jan; 63(1):29-36. PubMed ID: 24052136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity.
    Vanpouille-Box C; Diamond JM; Pilones KA; Zavadil J; Babb JS; Formenti SC; Barcellos-Hoff MH; Demaria S
    Cancer Res; 2015 Jun; 75(11):2232-42. PubMed ID: 25858148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intersection of radiotherapy and immunotherapy: mechanisms and clinical implications.
    Spiotto M; Fu YX; Weichselbaum RR
    Sci Immunol; 2016 Sep; 1(3):. PubMed ID: 28018989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy and Immunotherapy: Improving Cancer Treatment through Synergy.
    Reynders K; De Ruysscher D
    Prog Tumor Res; 2015; 42():67-78. PubMed ID: 26383848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors.
    Eckert F; Zwirner K; Boeke S; Thorwarth D; Zips D; Huber SM
    Front Immunol; 2019; 10():407. PubMed ID: 30930892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.